MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Intermediaries
Private Equity, Investment Banking, Financial Services, Factoring
Analysts, Investment Banks: Top Performing Recommendations & Analysis
Finance & Acquisitions: BAKER BROTHERS ADVISORS LP
Sangamo Therapeutics, Inc. (NASDAQ:SGMO)*
Finance & Acquisition: Sangamo
Parents
Sangamo Therapeutics, Inc. (NASDAQ:SGMO)*
Children
2014: 2014: Biogen Idec forges a $320M gene editing deal aimed at curing inherited blood disorders (2014)
2018: Sangamo in $3 billion gene-editing deal with Gilead
2022: Sangamo Therapeutics (SGMO) Investor Presentation - Slideshow_seekingalpha.com
2025: Sangamo Therapeutics, Inc. 2024 Q4 - Results - Earnings Call Presentation
Revenue: 111.3 million USD (2022)
Sangamo Therapeutics Inc Stock Quote: SGMO Stock News, Quotes, Analysis
Sangamo Therapeutics, Inc. Common Stock (SGMO) Analyst Research
TxCell, SA
Jumps
*Key People: Sangamo
Organization & Developments: Sangamo